fonda profit share, page-20

Yes; sure a 'sobering' time for biotech investors.

I just checked the US clinical trial website for the ACL Phase 3 trial

http://clinicaltrials.gov/ct2/show/NCT01290783?term=colon+cancer+HA-irinotecan&rank=1

Seems like there have been no updates for over 12 months. Hopefully others better understand the 'words', but seems to me it's saying patients will stay on the the trial for up to (?) 8 months. And, I guess we're well past that date from time of final recruitment? And, then there's mention of a 20 month 'monitoring' phase !

Like a lot of others, I'm assuming the longer it takes to 'data-lock' the better - but ....... Like a lot of others I'm holding (& hoping) - ACL is either worth 30 cents or $3